Carbohydrate Metabolism Practice Questions

Q: Glycogen storage disorders are primarily classified under which type of disorders?

Metabolic disorders. ***Metabolic disorders*** - Glycogen storage disorders involve defects in the enzymes responsible for **glycogen synthesis** or degradation. - These enzymatic defects lead to abnormal accumulation or breakdown of **glycogen**, thus affecting cellular metabolism. *Genetic disorders* - While glycogen storage disorders are **inherited** and thus genetic, their primary classification focuses on the **metabolic pathways** affected. - This category is too broad and refers to the origin, not the specific functional impairment. *Lysosomal storage disorders* - These disorders involve defective lysosomal enzymes leading to the accumulation of various **substrates within lysosomes**. - Glycogen storage disorders primarily involve enzymes in the **cytoplasm** (or sometimes lysosomes for Pompe disease, but the general classification is metabolic). *Endocrine disorders* - Endocrine disorders involve dysfunction of **hormone production** or regulation. - Glycogen storage diseases are disorders of **carbohydrate metabolism** and do not directly involve hormonal imbalance as their primary pathology.

Q: A cataract formation in both eyes was discovered in a 1-year-old child during a routine well-child visit, with blood tests showing elevated galactose and galactitol levels. To determine which enzyme might be defective in the child, which intracellular metabolite should be measured?

Galactose-1-phosphate. ***Galactose-1-phosphate*** - An elevation of **galactose-1-phosphate** in a patient with cataracts and elevated galactose and galactitol levels points to a deficiency in **galactose-1-phosphate uridyltransferase (GALT)**, indicating **classic galactosemia**. - The accumulation of **galactose-1-phosphate** is toxic and underlies the severe symptoms of classic galactosemia, including cataracts, liver damage, and intellectual disability. - Measuring this metabolite specifically identifies GALT deficiency and distinguishes it from other enzyme defects in galactose metabolism. *Galactose* - Elevated **galactose** is observed in **galactosemia**, but measuring galactose itself doesn't differentiate between the different enzyme deficiencies (e.g., GALT vs. GALK deficiency). - While elevated, it's the downstream metabolites like **galactose-1-phosphate** that are more specific for diagnosing the enzyme defect in classic galactosemia. *Fructose* - **Fructose** metabolism is distinct from galactose metabolism, and its levels would not be directly affected by defects in galactose-metabolizing enzymes. - Elevated fructose would suggest a different metabolic disorder, such as **hereditary fructose intolerance**, which has different clinical presentations. *Glucose* - **Glucose** levels are not specific for diagnosing enzyme defects in galactose metabolism. - While hypoglycemia can occur in severe galactosemia, measuring glucose doesn't identify which specific enzyme is deficient and is not the primary diagnostic metabolite.

Q: Pyruvate can be converted into all of the following in a single step except one.

Phosphoenol pyruvate. ***Phosphoenol pyruvate*** - The conversion of **pyruvate** to **phosphoenolpyruvate (PEP)** is not a single-step reaction but an energetically unfavorable two-step process in gluconeogenesis, involving **oxaloacetate** as an intermediate. - This conversion requires two enzymes: **pyruvate carboxylase** (to oxaloacetate) and **PEP carboxykinase** (to PEP), hence not a single step. *Alanine* - **Pyruvate** can be directly converted to **alanine** via transamination in a single step, catalyzed by **alanine transaminase**, with the addition of an amino group from glutamate. - This reaction is reversible and plays a key role in the **glucose-alanine cycle**. *Acetyl CoA* - **Pyruvate** is converted to **acetyl CoA** in a single, irreversible step by the **pyruvate dehydrogenase complex**, releasing **carbon dioxide**. - This is a crucial junction connecting glycolysis to the **citric acid cycle** and **fatty acid synthesis**. *Lactate* - **Pyruvate** can be directly reduced to **lactate** in a single step by **lactate dehydrogenase** during anaerobic glycolysis. - This reaction regenerates **NAD+**, essential for continuing glycolysis in the absence of oxygen.

Q: What can be prevented by inhibiting aldose reductase in diabetes mellitus?

Diabetic cataract. ***Diabetic cataract*** - **Aldose reductase** is the key enzyme in the **polyol pathway**, which converts glucose to **sorbitol**. - In diabetes, high glucose levels lead to excessive sorbitol accumulation in the **lens**, causing **osmotic stress** and contributing to cataract formation. - **Aldose reductase inhibitors are most effective** in preventing diabetic cataracts, as the lens has limited sorbitol metabolism capacity. *Deafness* - While diabetes can affect **hearing**, the primary mechanism is often related to **microvascular damage** rather than the direct action of aldose reductase. - Aldose reductase inhibition is not a primary strategy for preventing diabetic hearing loss. *Diabetic nephropathy* - This kidney complication of diabetes is primarily caused by **glomerular hypertrophy**, **basement membrane thickening**, and **mesangial expansion**. - While the polyol pathway might play a minor role, it's not the main driver of nephropathy, and aldose reductase inhibitors have not shown significant benefit in preventing it clinically. *Diabetic neuropathy* - The **polyol pathway does contribute** to diabetic neuropathy through sorbitol accumulation in peripheral nerves, causing osmotic stress and **myoinositol depletion**. - However, neuropathy is **multifactorial**, involving **microvascular ischemia**, **oxidative stress**, and **advanced glycation end products (AGEs)**. - While aldose reductase inhibitors have shown **some benefit** for neuropathy, they have had **limited clinical success** compared to their effectiveness in preventing cataracts, making diabetic cataract the **best answer** to this question.

Q: Which of the following enzymes catalyzes the rate-limiting irreversible step in glycolysis?

Phosphofructokinase. ***Phosphofructokinase*** - **Phosphofructokinase-1 (PFK-1)** catalyzes the phosphorylation of **fructose-6-phosphate** to **fructose-1,6-bisphosphate**, which is an **irreversible** and the **rate-limiting step** in glycolysis. - This enzyme is a major control point in glycolysis, regulated allosterically by several molecules including **ATP**, **AMP**, **citrate**, and **fructose-2,6-bisphosphate**. *Hexokinase* - **Hexokinase** catalyzes the initial phosphorylation of **glucose** to **glucose-6-phosphate**, which is an early irreversible step in glycolysis, but not the rate-limiting one. - This enzyme is inhibited by its product, **glucose-6-phosphate**, providing a feedback mechanism for regulating glucose entry into glycolysis. *Pyruvate kinase* - **Pyruvate kinase** catalyzes the final irreversible step in glycolysis, converting **phosphoenolpyruvate** to **pyruvate**. - While irreversible and a regulatory point, it is not considered the main rate-limiting step for the entire glycolysis pathway. *Aldolase* - **Aldolase** (fructose-1,6-bisphosphate aldolase) catalyzes a reversible step in glycolysis, cleaving **fructose-1,6-bisphosphate** into **dihydroxyacetone phosphate** and **glyceraldehyde-3-phosphate**. - This is not a rate-limiting step and the reaction is reversible.

Q: Maltase hydrolyzes maltose to form:

Two glucose molecules. ***Two glucose molecules*** - Maltase is an enzyme that specifically breaks down **maltose**. - Maltose, a disaccharide, is composed of **two glucose units** linked by an α-1,4-glycosidic bond. *Glucose and fructose* - This is the hydrolysis product of **sucrose**, a disaccharide broken down by the enzyme **sucrase**. - Sucrose consists of one **glucose** and one **fructose** molecule. *Galactose and fructose* - This combination does not represent a common disaccharide hydrolysis product. - While galactose and fructose are monosaccharides, they do not form a common dietary disaccharide linked together. *Glucose and galactose* - This is the hydrolysis product of **lactose**, a disaccharide broken down by the enzyme **lactase**. - Lactose is composed of one **glucose** and one **galactose** molecule.

Q: The uronic acid level in urine is elevated in what condition?

Mucopolysaccharidosis. ***Mucopolysaccharidosis*** - **Mucopolysaccharidoses (MPS)** are a group of genetic disorders caused by the deficiency of lysosomal enzymes responsible for breaking down **glycosaminoglycans (GAGs)**, which are also known as mucopolysaccharides. - The accumulation of these undegraded GAGs, which contain **uronic acids**, leads to their excretion in the urine, hence the elevated uronic acid levels. *Tyrosinosis* - **Tyrosinosis (Tyrosinemia)** is a metabolic disorder characterized by the inability to properly break down the amino acid **tyrosine**. - It leads to the accumulation of *tyrosine* and its derivatives, not uronic acids, in the body fluids. *Maple syrup urine disease* - **Maple syrup urine disease (MSUD)** is an autosomal recessive metabolic disorder affecting the metabolism of branched-chain amino acids (BCAAs): **leucine, isoleucine, and valine**. - The disease is characterized by a distinctive sweet smell in the urine, reminiscent of maple syrup, due to the accumulation of these amino acids and their ketoacid derivatives, not uronic acids. *Niemann-Pick disease* - **Niemann-Pick disease** is a group of rare, inherited metabolic disorders that affect the body's ability to metabolize fats (**lipids**) within cells. - It results from a deficiency of an enzyme called acid sphingomyelinase or a defect in intracellular cholesterol trafficking, leading to the accumulation of sphingomyelin and cholesterol in various organs.

Q: What is the optical rotation of D-glucose during mutarotation?

+52.7. ***+52.7*** - The **mutarotation** process involves the interconversion between the **α-anomer** (+112°) and **β-anomer** (+18.7°) of D-glucose in aqueous solution. - At **equilibrium**, the mixture contains approximately **36% α-D-glucose** and **64% β-D-glucose**. - The **equilibrium specific rotation** for D-glucose after mutarotation is **+52.7°** (or +52.5°), which is the final stable value reached when both anomers are in equilibrium. - This intermediate value reflects the weighted average of both anomeric forms. *+120* - This value does not correspond to any standard rotation value for D-glucose or its anomers. - Neither the initial α-D-glucose (+112°) nor the equilibrium mixture (+52.7°) has this rotation. *+105* - While this is a positive rotation, it is not the accurate equilibrium specific rotation for D-glucose after mutarotation. - This value does not match the experimentally determined equilibrium rotation of +52.7°. *-150* - This value is a **negative rotation** (levorotatory), which is not characteristic of D-glucose. - D-glucose is a **dextrorotatory** compound at all stages of mutarotation. - This magnitude and sign are completely inconsistent with D-glucose behavior.

Q: Which of the following glucose transporters mediates insulin-stimulated glucose uptake?

GLUT4. ***GLUT4*** - **GLUT4** is the only glucose transporter that is **insulin-sensitive**, meaning its translocation to the cell membrane is stimulated by insulin, leading to increased glucose uptake. - It is primarily found in **adipose tissue** and **striated muscle (skeletal and cardiac muscle)**, key tissues for insulin's actions. *SGLT-1* - **SGLT-1** (Sodium-Glucose Linked Transporter 1) is a **secondary active transporter** responsible for glucose and galactose absorption in the **small intestine** and reabsorption in the **kidney**. - Its activity is **not directly regulated by insulin**; it couples glucose transport with sodium co-transport. *GLUT1* - **GLUT1** is a **basal glucose transporter** found in nearly all tissues, especially the brain and red blood cells. - It maintains a **constant, low-level glucose uptake** independent of insulin and ensures a continuous supply of glucose to basal metabolic processes. *GLUT2* - **GLUT2** is a **low-affinity, high-capacity transporter** primarily located in the liver, pancreatic beta cells, kidney, and small intestine. - It is crucial for **glucose sensing in the pancreas** and for rapid glucose excretion or storage by the liver, but its activity is **not directly regulated by insulin** for uptake.

Question 1

Glycogen storage disorders are primarily classified under which type of disorders?

Accepted Answer

Metabolic disorders

Answer

Endocrine disorders

Answer

Genetic disorders

Answer

Lysosomal storage disorders

Question 2

A cataract formation in both eyes was discovered in a 1-year-old child during a routine well-child visit, with blood tests showing elevated galactose and galactitol levels. To determine which enzyme might be defective in the child, which intracellular metabolite should be measured?

Accepted Answer

Galactose-1-phosphate

Answer

Galactose

Answer

Fructose

Answer

Glucose

Question 3

Pyruvate can be converted into all of the following in a single step except one.

Accepted Answer

Phosphoenol pyruvate

Answer

Acetyl CoA

Answer

Lactate

Answer

Alanine

Question 4

What can be prevented by inhibiting aldose reductase in diabetes mellitus?

Accepted Answer

Diabetic cataract

Answer

Diabetic nephropathy

Answer

Deafness

Answer

Diabetic neuropathy

Question 5

Which of the following enzymes catalyzes the rate-limiting irreversible step in glycolysis?

Accepted Answer

Phosphofructokinase

Answer

Hexokinase

Answer

Aldolase

Answer

Pyruvate kinase

Question 6

Maltase hydrolyzes maltose to form:

Accepted Answer

Two glucose molecules

Answer

Glucose and fructose

Answer

Galactose and fructose

Answer

Glucose and galactose

Question 7

The uronic acid level in urine is elevated in what condition?

Accepted Answer

Mucopolysaccharidosis

Answer

Tyrosinosis

Answer

Maple syrup urine disease

Answer

Niemann-Pick disease

Question 8

What is the optical rotation of D-glucose during mutarotation?

Accepted Answer

+52.7

Answer

a +120

Answer

d +105

Answer

b -150

Question 9

Which of the following statements about the enzyme aldolase B is false?

Accepted Answer

The enzyme involved catalyzes the conversion of fructose to fructose-1 phosphate

Answer

The enzyme cleaves fructose-1-phosphate into dihydroxyacetone phosphate and glyceraldehyde

Answer

The enzyme is involved in fructose metabolism

Answer

The enzyme is found primarily in liver, kidney, and intestine

Question 10

Which of the following glucose transporters mediates insulin-stimulated glucose uptake?

Accepted Answer

GLUT4

Answer

SGLT-1

Answer

GLUT2

Answer

GLUT1

Carbohydrate Metabolism — MCQs

Carbohydrate Metabolism — MCQs

On this page

Practice by Chapter

Want unlimited practice?